Literature DB >> 12838284

Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration.

T Kitawaki1, N Kadowaki, T Ishikawa, T Ichinohe, T Uchiyama.   

Abstract

Delayed recovery of the immune system is a major cause of post-transplant infection. Natural interferon (IFN)-alpha/beta-producing cells (IPC) appear to play a critical role in inducing effective immune responses to a variety of microbial pathogens by producing an enormous amount of IFN-alpha/beta and thereafter by differentiating into dendritic cells. Here, we examined the recovery of IPC as well as other immune cells in 28 patients after allogeneic hematopoietic stem cell transplantation (HSCT) in order to investigate the role of IPC in post-transplant immune reconstitution. In uncomplicated cases, IPC frequency recovered to the lower range of normal values within 30 days after transplantation, resembling the prompt recovery of other cell types in innate immunity. In contrast, the recovery of IPC was profoundly suppressed in the cases with acute graft-versus-host disease (GVHD) and glucocorticoid administration. The patients with lower numbers of IPC were significantly more susceptible to viral infection. The prompt recovery of IPC in uncomplicated cases may contribute to establishing a first line of host defense at the early stage after allogeneic HSCT, whereas the marked suppression of IPC recovery accompanying acute GVHD and glucocorticoid administration may increase the risk of opportunistic infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12838284     DOI: 10.1038/sj.bmt.1704093

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.

Authors:  Takayuki Sato; Tatsuo Ichinohe; Junya Kanda; Kouhei Yamashita; Tadakazu Kondo; Takayuki Ishikawa; Takashi Uchiyama; Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2011-04-05       Impact factor: 2.490

Review 2.  Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?

Authors:  J J Auletta; S M Devine; E K Waller
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

3.  Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning.

Authors:  Chisaki Mizumoto; Junya Kanda; Tatsuo Ichinohe; Takayuki Ishikawa; Masashi Matsui; Norimitsu Kadowaki; Tadakazu Kondo; Kazunori Imada; Masakatsu Hishizawa; Hiroshi Kawabata; Momoko Nishikori; Kouhei Yamashita; Akifumi Takaori-Kondo; Toshiyuki Hori; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2009-04-11       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.